What is Propranolol Used For?
Propranolol is a nonselective beta-adrenergic receptor blocker used primarily for cardiovascular conditions (hypertension, angina, arrhythmias, myocardial infarction), infantile hemangiomas, migraine prophylaxis, essential tremor, anxiety with prominent physical symptoms, hyperthyroidism, and portal hypertension. 1
Primary Cardiovascular Indications
Propranolol's cardiovascular applications stem from its ability to block beta-adrenergic receptors, reducing heart rate, cardiac output, and blood pressure 1:
- Hypertension: Reduces blood pressure through decreased cardiac output, inhibition of renin release, and diminished sympathetic outflow from the brain 1
- Angina pectoris: Decreases myocardial oxygen demand by blocking catecholamine-induced increases in heart rate, blood pressure, and myocardial contractility 1, 2
- Cardiac arrhythmias: Exerts antiarrhythmic effects through beta-blockade and quinidine-like membrane stabilization 1, 2
- Post-myocardial infarction: Reduces mortality when used after heart attack 3
- Hypertrophic cardiomyopathy: Controls symptoms related to excessive cardiac contractility 2
Infantile Hemangiomas (First-Line Treatment)
Propranolol is the first-line treatment for proliferating infantile hemangiomas requiring intervention, with an 86-91% response rate. 4
Specific Indications for Treatment 4:
- Ulcerated hemangiomas: Particularly those causing pain or bleeding
- Functional impairment:
- Risk of disfigurement: Central face, nose, lips, and ear lesions that distort anatomical landmarks 4
Dosing for Infantile Hemangiomas 4:
- Standard starting dose: 1 mg/kg/day divided into three doses, increased to 2 mg/kg/day after 24 hours
- High-risk patients (preterm, comorbidities): Start at 0.5 mg/kg/day with inpatient monitoring
- Treatment duration: Most cases can stop at 12 months of age; majority don't need treatment beyond 17 months 4
- Response timeline: Color lightening and softening typically occurs within hours to days 4
Neurological and Psychiatric Conditions
- Migraine prophylaxis: Mechanism unclear but likely involves beta-receptor blockade in pial brain vessels 1, 2, 3
- Essential tremor: Controls tremor through peripheral beta-blockade 2, 3
- Performance anxiety: Most effective for physical/somatic symptoms (tremor, palpitations, tachycardia, sweating) rather than cognitive anxiety 5, 6
Other Established Uses
- Hyperthyroidism: Controls sympathetic overactivity symptoms (tachycardia, tremor) 2, 7
- Pheochromocytoma: Manages catecholamine excess (only after alpha-blockade established) 8, 2
- Portal hypertension: Prevents upper gastrointestinal bleeding in cirrhotic patients 2, 3
Critical Contraindications (Absolute)
Never use propranolol in patients with: 5, 6
- Second or third-degree heart block
- Decompensated heart failure or cardiogenic shock
- Asthma or severe reactive airway disease
- Sinus bradycardia (HR below normal for age)
- Active bronchospasm
Essential Pre-Treatment Assessment
Before initiating propranolol, perform 4, 6:
- Cardiovascular examination: Auscultation for murmurs, peripheral pulse palpation, heart rate and blood pressure measurement
- ECG indicated if: Abnormal heart rate for age, family history of sudden death/arrhythmia, syncope episodes, maternal connective tissue disease 4
- Echocardiogram required for: Segmental infantile hemangiomas, heart murmurs, abnormal heart rate 4
- Screening for: Bronchospasm history, diabetes (propranolol masks hypoglycemia), concurrent cardiac medications 5, 6
Common Pitfalls and Safety Warnings
- Never abruptly discontinue: Can precipitate rebound hypertension, tachycardia, or angina—always taper gradually 5, 6
- Hypoglycemia masking: Propranolol blocks adrenergic symptoms of low blood sugar in diabetics; counsel patients accordingly 6, 9
- Feeding requirement for infants: Must maintain regular feeds to prevent hypoglycemia; stop propranolol if oral intake decreases 4
- Drug interactions: Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to severe bradycardia risk 5
- Sleep disturbances: Occur in 2-18.5% of patients, including nightmares and night terrors 9